S

Samsung Medical Center | Biomedical Statistics Center

Research site
(Unclaimed)
Location
81 Irwon-ro, Gangnam-gu, Seoul, Seoul, South Korea
Site insights

Top conditions

Prostatic Cancer (1 trial)

Endometrial Cancer (1 trial)

Top treatments

Paclitaxel
Doxorubicin
MK-5684

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

2 of 2
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
MK-2870 in Post Platinum and Post Immunotherapy Endometrial Cancer (MK-2870-005)

The primary objectives of this study are to compare MK-2870 to Treatment of Physician's Choice (TPC) with respect to progression-free survival (PFS)...

Enrolling
Endometrial Cancer
Biological: MK-2870
Drug: Doxorubicin

This is a phase 3, randomized, open-label study of MK-5684 compared to alternative abiraterone acetate or enzalutamide in participants with metastati...

Enrolling
Prostate Cancer Metastatic
Drug: Fludrocortisone acetate
Drug: Dexamethasone

Trial sponsors

Merck Sharp & Dohme (MSD) logo

Merck Sharp & Dohme (MSD) (2 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems